NASDAQ:KTWO

K2M Group (KTWO) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$27.50
$27.50
50-Day Range
N/A
52-Week Range
$16.44
$27.50
Volume
N/A
Average Volume
1.85 million shs
Market Capitalization
$1.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
KTWO stock logo

About K2M Group Stock (NASDAQ:KTWO)

K2M Group Holdings, Inc., a medical device company, provides spine and minimally invasive solutions in the United States and internationally. The company offers implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor. Its complex spine products include EVEREST, MESA, and MESA 2 deformity spinal systems; NILE alternative and proximal fixation spinal systems; MESA rail deformity spinal systems; Cricket spinal correction rod reduction instrumentation; CAPRI corpectomy cage systems; MESA small stature, rail small stature, and mini spinal systems; SERENGETI complex spine minimally invasive retractor systems; RAVINE complex spine lateral access systems; SANTORINI corpectomy cage systems; YUKON OCT spinal systems; and PALO ALTO cervical static corpectomy cage systems. The company's minimally invasive surgery products consist of EVEREST minimally invasive spinal and XT spinal, SERENGETI minimally invasive retractor, MOJAVE PL 3D expandable interbody, RAVINE lateral access, CASCADIA lateral 3D interbody, ALEUTIAN lateral interbody, and TERRA NOVA minimally invasive access systems. In addition, its degenerative spine products comprise EVEREST degenerative spinal, CASCADIA and ALEUTIAN interbody, SAHARA AL expandable stabilization, RHINE cervical disc, CHESAPEAKE interbody, PYRENEES cervical plate, and BLUE RIDGE hybrid cervical plate systems. Further, the company provides Balance ACS, a platform that includes tools to assist surgeons with obtaining authorization from healthcare insurers. K2M Group Holdings, Inc. markets and sells its products through direct sales employees, independent sales agencies, and distributor partners. The company was founded in 2004 and is headquartered in Leesburg, Virginia.

KTWO Stock News Headlines

K2M Group Holdings Inc (KTWO)
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
See More Headlines
Receive KTWO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for K2M Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/01/2018
Today
4/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:KTWO
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-37,140,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$258.03 million
Book Value
$5.59 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.20 billion
Optionable
Optionable
Beta
1.43
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Eric D. Major (Age 48)
    Co-Founder, Chairman, CEO & Pres
  • Dr. John Phillip Kostuik (Age 80)
    Co-Founder, Chief Medical Officer & Director
  • Mr. Gregory S. Cole (Age 48)
    Chief Financial Officer
  • Mr. Lane E. Major (Age 39)
    Chief Operating Officer
  • Mr. Dave B. MacDonald
    Sr. VP of Operations

KTWO Stock Analysis - Frequently Asked Questions

How were K2M Group's earnings last quarter?

K2M Group Holdings, Inc. (NASDAQ:KTWO) issued its quarterly earnings results on Wednesday, August, 1st. The medical device company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.06. The medical device company had revenue of $73.58 million for the quarter, compared to analyst estimates of $70.85 million. K2M Group had a negative trailing twelve-month return on equity of 19.69% and a negative net margin of 16.66%. The firm's quarterly revenue was up 12.0% on a year-over-year basis. During the same quarter last year, the company earned ($0.21) EPS.

What other stocks do shareholders of K2M Group own?
This page (NASDAQ:KTWO) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners